XOMA Royalty (XOMA) Revenue (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Revenue came in at $12.3 million in Q1 2026, up 207.95% year-on-year from $4.0 million in Q1 2025, and down 71.29% quarter-over-quarter from $42.9 million in Q4 2025.
XOMA Royalty (XOMA) Revenue (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Revenue across 16 years of filings, most recently posting $12.3 million for Q1 2026.
- Revenue for Q1 2026 came in at $12.3 million, up 207.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.5 million (up 533.16% YoY), and the FY2025 annual result was $52.1 million, up 83.06% from the prior year.
- Revenue came in at $12.3 million for Q1 2026 at XOMA Royalty, down from $42.9 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $42.9 million in Q4 2025 to a low of $25000.0 in Q3 2024.
- The 5-year median for Revenue is $1.5 million (2022), against an average of $4.8 million.
- Across the five-year window, Revenue tumbled 96.99% in 2024 and jumped 8479.8% in 2025, its largest moves.
- XOMA Royalty's Revenue stood at $1.5 million in 2022, then advanced by 23.35% to $1.8 million in 2023, then plunged by 72.72% to $500000.0 in 2024, then surged by 8479.8% to $42.9 million in 2025, then sank by 71.29% to $12.3 million in 2026.
- The last three Revenue figures came in at $12.3 million (Q1 2026), $42.9 million (Q4 2025), and $225000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.57 Mn | - | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.32 Mn |
| Dec 31, 2025 | 42.90 Mn |
| Sep 30, 2025 | 225,000.00 |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 5.03 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 830,000.00 |
| Jun 30, 2023 | 688,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 451,000.00 |
| Jun 30, 2022 | 983,000.00 |
| Mar 31, 2022 | 3.11 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 940,000.00 |
| Jun 30, 2021 | 901,000.00 |